advertisement
Huang J 19
Showing records 1 to 19 |
Display all abstracts from Huang J73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjectsLin J
PLoS ONE 2017; 12: e0177769
72873 Willingness to Use Mobile Health in Glaucoma PatientsDai M
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationHuang J
AAPS PharmSciTech 2017; 18: 2919-2926
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjectsWang Z
PLoS ONE 2017; 12: e0177769
72873 Willingness to Use Mobile Health in Glaucoma PatientsXu J
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationPeng T
AAPS PharmSciTech 2017; 18: 2919-2926
72873 Willingness to Use Mobile Health in Glaucoma PatientsLin J
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjectsChung C
PLoS ONE 2017; 12: e0177769
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationLi Y
AAPS PharmSciTech 2017; 18: 2919-2926
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjectsXu J
PLoS ONE 2017; 12: e0177769
72873 Willingness to Use Mobile Health in Glaucoma PatientsWang Z
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationZhan Z
AAPS PharmSciTech 2017; 18: 2919-2926
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjectsDai M
PLoS ONE 2017; 12: e0177769
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationZeng Y
AAPS PharmSciTech 2017; 18: 2919-2926
72873 Willingness to Use Mobile Health in Glaucoma PatientsHuang W
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationHuang Y
AAPS PharmSciTech 2017; 18: 2919-2926
72873 Willingness to Use Mobile Health in Glaucoma PatientsHuang J
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjectsHuang J
PLoS ONE 2017; 12: e0177769
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo EvaluationPan X; Wu CY; Wu C
AAPS PharmSciTech 2017; 18: 2919-2926
Issue 18-4
Change Issue
advertisement